American Shared Hospital Services (NYSEAMERICAN:AMS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a research report report published on Saturday. The brokerage issued a hold rating on the stock.

American Shared Hospital Services Price Performance

NYSEAMERICAN AMS opened at $3.18 on Friday. The company has a current ratio of 1.98, a quick ratio of 1.98 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $20.13 million, a P/E ratio of 39.75 and a beta of 0.70. American Shared Hospital Services has a 1 year low of $2.16 and a 1 year high of $3.69.

American Shared Hospital Services (NYSEAMERICAN:AMS) last posted its earnings results on Tuesday, May 14th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.01). The business had revenue of $5.22 million during the quarter, compared to the consensus estimate of $5.01 million. American Shared Hospital Services had a return on equity of 4.29% and a net margin of 2.50%. As a group, research analysts predict that American Shared Hospital Services will post 0.29 EPS for the current fiscal year.

Institutional Trading of American Shared Hospital Services

A hedge fund recently bought a new stake in American Shared Hospital Services stock. Empowered Funds LLC acquired a new position in American Shared Hospital Services (NYSEAMERICAN:AMS) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned about 0.17% of American Shared Hospital Services as of its most recent SEC filing. 23.16% of the stock is currently owned by hedge funds and other institutional investors.

About American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.